FILTER

LATEST INTERVIEWS

Mining
Ghana
MACIG

Douglas MacQuarrie & Bashir Ahmed

PRESIDENT AND CEO & VICE PRESIDENT PRODUCTION AND DEVELOPMENT, ASANTE GOLD
Asante Gold is benefiting from strong gold prices to bring its Kubi mine in Ghana to production.
Mining
Canada

Duncan Middlemiss

PRESIDENT & CEO, WESDOME GOLD MINES
Mining in Ontario and Toronto's Global Reach 2020
Wesdome Gold Mines is enjoying improving market conditions at its mines in Québec and Ontario.
Mexico
Petrochemicals & Chemicals

Martin Toscano

MANAGING DIRECTOR, EVONIK INDUSTRIES (MEXICO)
Evonik Mexico benefits from the country’s increasingly export-based economy.
United States
Pharma & Life Sciences

Rajiv Anand

FOUNDER AND CEO, QUARTIC.AI
AI in the Life Sciences 2020
Quartic AI explains how artificial intelligence and machine learning should be applied in life sciences.
Mining
Peru

Sandro Tavonatti

CEO, INGENIERÍA Y CONSTRUCCIÓN SIGDO KOPPERS
Ingeniería y Construcción Sigdo Koppers in Peru comments on its ongoing projects in the mining sector in Peru.
Mining
DRC
MACIG

Louis Watum

PRESIDENT OF THE CHAMBER OF MINES, DRC
The Chamber of Mines of the DRC explains the conditions relating to the mining industry there.
Mining
Peru

Jorge León Benavides

PRESIDENT, CHAMBER OF COMMERCE CANADA PERU (CCCP)
Jorge León Benavides explains how the CCCP promotes business and investment in Peru.
Mining
Canada

Mark Selby

CHAIR & CEO, CANADA NICKEL COMPANY
Canada Nickel Company is developing a large nickel project at Crawford, north of Timmins.
Mining
Peru

Ricardo Ishida

GENERAL MANAGER – PERÚ, LIEBHERR
Liebherr began operations in Peru in 2019 and describes how it plans to penetrate the market with its trucks and shovels.
Mining
Canada

Doug Ramshaw

PRESIDENT, MINERA ALAMOS
Minera Alamos has put together some exciting gold projects in Mexico and explains their development plans.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL